| Financial Year |
March 31 2023 |
| Monetary Funds |
3,421,383,842.35 |
| Held-for-trading Financial Assets |
18,113,951.56 |
| Notes Receivable |
8,391,144.25 |
| Accounts Receivable |
1,616,466,707.30 |
| Advances to Suppliers |
368,671,025.91 |
| Other Receivables |
255,105,119.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,861,912,790.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
368,288.28 |
| Other Current Assets |
173,284,840.72 |
| Total Current Assets |
9,945,291,683.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
143,439,914.84 |
| Long-term Equity Investment |
1,157,467,945.29 |
| Investment Properties |
111,447,782.59 |
| Fixed Assetes |
5,064,355,628.53 |
| Under-construction Projects |
2,548,567,769.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
934,272,186.39 |
| R&D expenses |
-- |
| Goodwill |
211,068,126.84 |
| Long-Term Deferred and Prepaid Expenses |
12,884,860.14 |
| Deferred Income Tax Assets |
94,368,104.36 |
| Other Non-Current Assets |
337,637,239.69 |
| Sub-Total of Non-Current Assets |
10,803,275,140.71 |
| Total Assets |
20,748,566,824.35 |
| Short-Term Loans |
754,351,988.19 |
| Trading Financial liabilities |
962,429.32 |
| Notes Payable |
1,531,402,733.99 |
| Accounts Payable |
2,081,406,789.97 |
| Accounts Received In Advance |
296,047.35 |
| Employee Compensation Payable |
94,874,343.05 |
| Taxes Payable |
135,800,384.86 |
| Interest Payable |
-- |
| Dividend Payable |
65,448,747.91 |
| Other payables |
205,686,881.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
380,741,800.11 |
| Other Current Liabilities |
45,928,850.04 |
| Sub-Total of Current Liabilities |
5,838,870,585.31 |
| Long-term Loans |
1,874,113,910.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
122,639,463.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,055,523.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,122,156,336.65 |
| Total Liabilities |
7,961,026,921.96 |
| Paid-In Capital(Or Share Stock) |
1,145,746,540.00 |
| Capital Surplus |
650,378,026.25 |
| Surplus Reserve |
572,873,270.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,192,664,229.64 |
| Minority Stockholder's Interest |
1,124,595,684.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,662,944,217.54 |
| Owner's Equity（Stockholder's Equity） |
12,787,539,902.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,748,566,824.35 |
